134 related articles for article (PubMed ID: 36697389)
1. Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors.
Massarotti C; Asinaro G; Schiaffino MG; Ronzini C; Vacca I; Lambertini M; Anserini P; Del Mastro L; Cagnacci A
Climacteric; 2023 Apr; 26(2):129-134. PubMed ID: 36697389
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study.
Hersant B; SidAhmed-Mezi M; Belkacemi Y; Darmon F; Bastuji-Garin S; Werkoff G; Bosc R; Niddam J; Hermeziu O; La Padula S; Meningaud JP
Menopause; 2018 Oct; 25(10):1124-1130. PubMed ID: 29738415
[TBL] [Abstract][Full Text] [Related]
3. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
[TBL] [Abstract][Full Text] [Related]
4. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
[TBL] [Abstract][Full Text] [Related]
5. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
[TBL] [Abstract][Full Text] [Related]
7. Conjugate treatment with high concentration normobaric oxygen and hyaluronic acid for vaginal atrophy: a prospective study.
Barbero M; Villasco A; Villa M; Badellino E; Marello E; Botta G
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2011-2017. PubMed ID: 36930500
[TBL] [Abstract][Full Text] [Related]
8. Vaginal natural oxygenation device (VNOD) for concomitant administration of hyaluronic acid and topical hyperbaric oxygen to treat vulvo-vaginal atrophy: a pilot study.
Condemi L; Di Giuseppe J; Delli Carpini G; Garoia F; Frega A; Ciavattini A
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8480-8486. PubMed ID: 30556890
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review.
Dos Santos CCM; Uggioni MLR; Colonetti T; Colonetti L; Grande AJ; Da Rosa MI
J Sex Med; 2021 Jan; 18(1):156-166. PubMed ID: 33293236
[TBL] [Abstract][Full Text] [Related]
10. Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Gold D; Nicolay L; Avian A; Greimel E; Balic M; Pristauz-Telsnigg G; Tamussino K; Trutnovsky G
Maturitas; 2023 Jan; 167():1-7. PubMed ID: 36279690
[TBL] [Abstract][Full Text] [Related]
11. Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia.
Sánchez-Prieto M; Pingarrón C; Bergamaschi L; Bermúdez JC; Subiris González J; Sánchez Sánchez R; Poyo Torcal S; Gómez M; Ruiz Pérez ML; Castillo Martínez M; Peña Penedo ME; Sánchez-Borrego R
Gynecol Endocrinol; 2024 Mar; 40(1):2317268. PubMed ID: 38468593
[TBL] [Abstract][Full Text] [Related]
12. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study.
Berreni N; Salerno J; Chevalier T; Alonso S; Mares P
BMC Womens Health; 2021 Aug; 21(1):322. PubMed ID: 34454465
[TBL] [Abstract][Full Text] [Related]
14. Comparable Efficacy of Submucosal Platelet-Rich Plasma and Combined Platelet-Rich Plasma Noncrosslinked Hyaluronic Acid Injections in Vulvovaginal Atrophy: A Cancer Survivorship Issue.
Omar SS; Elmulla KF; AboKhadr NA; Badawy AA; Ramadan EN; Hassouna AM; Heikal LA; Arafat WO
J Womens Health (Larchmt); 2023 Sep; 32(9):1006-1020. PubMed ID: 37417970
[No Abstract] [Full Text] [Related]
15. Lower urinary tract symptoms and their relation to vaginal atrophy in women across the menopausal age span. Results from the ANGEL multicentre observational study.
Cagnacci A; Sclauzero M; Meriggiola C; Xholli A;
Maturitas; 2020 Oct; 140():8-13. PubMed ID: 32972638
[TBL] [Abstract][Full Text] [Related]
16. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
[TBL] [Abstract][Full Text] [Related]
17. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
Gambacciani M; Levancini M
Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
[TBL] [Abstract][Full Text] [Related]
18. Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study.
Mension E; Alonso I; Cebrecos I; Castrejon N; Tortajada M; Matas I; Gómez S; Ribera L; Anglès-Acedo S; Castelo-Branco C
Climacteric; 2022 Oct; 25(5):476-482. PubMed ID: 35343852
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; BSc AB; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731
[TBL] [Abstract][Full Text] [Related]
20. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
Cagnacci A; Barattini DF; Casolati E; Pecoroni A; Mangrella M; Patrascu LC
Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():239-245. PubMed ID: 35131532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
